Purpose: Cryptogenic epilepsy, the group of epilepsy syndromes for which an
etiology is unknown, comprises similar to 20% of all epilepsy syndromes. W
e selected patients in this subgroup of epilepsy and tested them for eviden
ce of Toxoplasma gondii IgG antibodies by the enzyme-linked immunosorbent a
ssay. T. gondii is found in up to 20% of the U.S. population forming dorman
t brain cysts in the latent bradyzoite form. We investigated the hypothesis
that dormant T. gondii infection might be associated with cryptogenic epil
epsy.
Methods: We selected patients with cryptogenic epilepsies and tested them f
or evidence of T. gondii IgG antibodies by the enzyme-linked immunosorbent
assay. A control group was also tested for comparison.
Results: We have found a statistically-significant elevation of T. gondii a
ntibodies among cryptogenic epilepsy patients as compared to controls [59%
increase in optical density (OD), p = 0.013]. This association persisted af
ter adjustment for subjects' gender and age in a multiple logistic regressi
on model; however, it was no longer as statistically significant.
Conclusions: Our results suggest that chronic T. gondii infection with brai
n cysts may be a cause of cryptogenic epilepsy.